NORADRENERGIC AND NEUROPEPTIDE-Y MECHANISMS IN GUANETHIDINE-SYMPATHECTOMIZED RATS

[1] FACTORS CONTRIBUTING TO THE MAINTENANCE OF ARTERIAL BLOOD-PRESSURE IN ADULT-RATS TREATED NEONATALLY WITH GUANETHIDINE [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1986, 8 (08) : 1373 - 1394

[2] SYMPATHETIC POST-GANGLIONIC UNMYELINATED AXONS IN THE RAT PERIPHERAL NERVOUS-SYSTEM [J]. NEUROLOGY, 1983, 33 (07) : 841 - 847

[3] DETERMINATION OF RAT-BRAIN TISSUE CATECHOLAMINES USING LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J]. JOURNAL OF CHROMATOGRAPHY, 1981, 222 (01): : 107 - 111

[4] GUANETHIDINE-INDUCED DESTRUCTION OF SYMPATHETIC NEURONS [J]. INTERNATIONAL REVIEW OF NEUROBIOLOGY, 1984, 25 : 1 - 37

[5] JOHNSON EM, 1976, J PHARMACOL EXP THER, V196, P53

[6] JUUL P, 1973, ACTA PHARMACOL TOX, V32, P487

[7] DISTRIBUTION, QUANTITATION, AND ORIGIN OF IMMUNOREACTIVE NEUROPEPTIDE-Y IN THE HUMAN GASTROINTESTINAL-TRACT [J]. REGULATORY PEPTIDES, 1988, 21 (3-4) : 309 - 319

[8] LUNDBERG J M, 1987, Journal of Cardiovascular Pharmacology, V10, pS51, DOI 10.1097/00005344-198710012-00008

[9] GUANETHIDINE-SENSITIVE RELEASE OF NEUROPEPTIDE Y-LIKE IMMUNOREACTIVITY IN THE CAT SPLEEN BY SYMPATHETIC-NERVE STIMULATION [J]. NEUROSCIENCE LETTERS, 1984, 52 (1-2) : 175 - 180

[10] HIGH-LEVELS OF NEUROPEPTIDE-Y IN PERIPHERAL NORADRENERGIC NEURONS IN VARIOUS MAMMALS INCLUDING MAN [J]. NEUROSCIENCE LETTERS, 1983, 42 (02) : 167 - 172

[1] FACTORS CONTRIBUTING TO THE MAINTENANCE OF ARTERIAL BLOOD-PRESSURE IN ADULT-RATS TREATED NEONATALLY WITH GUANETHIDINE [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1986, 8 (08) : 1373 - 1394

[2] SYMPATHETIC POST-GANGLIONIC UNMYELINATED AXONS IN THE RAT PERIPHERAL NERVOUS-SYSTEM [J]. NEUROLOGY, 1983, 33 (07) : 841 - 847

[3] DETERMINATION OF RAT-BRAIN TISSUE CATECHOLAMINES USING LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J]. JOURNAL OF CHROMATOGRAPHY, 1981, 222 (01): : 107 - 111

[4] GUANETHIDINE-INDUCED DESTRUCTION OF SYMPATHETIC NEURONS [J]. INTERNATIONAL REVIEW OF NEUROBIOLOGY, 1984, 25 : 1 - 37

[5] JOHNSON EM, 1976, J PHARMACOL EXP THER, V196, P53

[6] JUUL P, 1973, ACTA PHARMACOL TOX, V32, P487

[7] DISTRIBUTION, QUANTITATION, AND ORIGIN OF IMMUNOREACTIVE NEUROPEPTIDE-Y IN THE HUMAN GASTROINTESTINAL-TRACT [J]. REGULATORY PEPTIDES, 1988, 21 (3-4) : 309 - 319

[8] LUNDBERG J M, 1987, Journal of Cardiovascular Pharmacology, V10, pS51, DOI 10.1097/00005344-198710012-00008

[9] GUANETHIDINE-SENSITIVE RELEASE OF NEUROPEPTIDE Y-LIKE IMMUNOREACTIVITY IN THE CAT SPLEEN BY SYMPATHETIC-NERVE STIMULATION [J]. NEUROSCIENCE LETTERS, 1984, 52 (1-2) : 175 - 180

[10] HIGH-LEVELS OF NEUROPEPTIDE-Y IN PERIPHERAL NORADRENERGIC NEURONS IN VARIOUS MAMMALS INCLUDING MAN [J]. NEUROSCIENCE LETTERS, 1983, 42 (02) : 167 - 172